- Approval Id
- 5fbcf646a8a5ef4c
- Drug Name
- ILIADIN SOLUTION 0.05%
- Product Name
- ILIADIN SOLUTION 0.05%
- Approval Number
- SIN03163P
- Approval Date
- 1989-06-02
- Registrant
- PROCTER & GAMBLE (SINGAPORE ) PTE LTD
- Licence Holder
- PROCTER & GAMBLE (SINGAPORE) PTE LTD
- Drug Type
- Therapeutic
- Forensic Classification
- GENERAL SALE LIST
- Dosage Form
- SOLUTION
- Dosage
- <p><strong>Dosage, mode of administration</strong></p>
<img src="/TGIF/IliadinSolution-Image1.png" alt="Iliadin Solution 0.05% Dosage Image 1" /><br><br>
<p>Iliadin 0.05% Decongestant Nasal Drops is intended for intranasal application. Unless otherwise prescribed, instill 1–2 drops of Iliadin 0.05% Decongestant Nasal Drops into each nostril 2–3 times daily.</p>
<p>Iliadin 0.05% Decongestant Nasal Drops may only be administered to adults and children of 6 years and older and should not be used in small children and infants.</p>
<p><strong>Duration of treatment</strong><br>
Unless specifically prescribed by the doctor, Iliadin 0.05% Decongestant Nasal Drops should only be used for short periods of time (5 to 7 days). A treatment-free period of several days should precede any repeated use.</p>
<p>Permanent use of decongestant rhinological agents may attenuate their effect. The abuse of local rhinological agents may cause mucosal atrophy and reactive hyperaemia with rhinitis medicamentosa.</p>
<p>Longer use of oxymetazoline may cause damage to the mucosal epithelium with inhibition of ciliary activity. This may possibly result in irreversible damage to the mucosa with rhinitis sicca.</p>
<p>Long term use and overdosage must be avoided, especially in children. Medical supervision is indicated in patients with chronic rhinitis. Dosage higher than recommended may only be used under supervision.</p>
- Route Of Administration
- NASAL
- Indication Info
- <p><strong>Indications</strong><br>
Acute cold, paranasal sinusitis, syringitis, otitis media.</p>
- Contraindications
- <p><strong>Contraindications</strong><br>
Rhinitis sicca, hypersensitivity to the active ingredient or to any of the excipients, children below six years of age.</p>
<p>In the following cases this drug may only be used after carefully weighing the risk-to-benefit ratio:</p>
<ul class="dash">
<li>Patients treated with monamine oxidase inhibitors (MAO-inhibitors) and other drugs potentially increasing blood pressure</li>
<li>Increased intraocular pressure, especially narrow-angle glaucoma</li>
<li>Severe cardiovascular diseases (e.g. coronary heart disease, hypertension)</li>
<li>Phaeochromocytoma</li>
<li>Metabolic disorders (e.g. hyperthyroidism, diabetes mellitus, porphyria).</li>
<li>Hyperplasia of the prostate</li>
</ul>
<p>Because of the benzalkonium chloride which is contained as preservative Iliadin 0.05% Decongestant Nasal Drops must not be used in known hypersensitivity to this substance.</p>
- Atc Code
- R01AA05
- Atc Item Name
- oxymetazoline
- Pharma Manufacturer Name
- PROCTER & GAMBLE (SINGAPORE) PTE LTD
- Company Detail Path
- /organization/procter-and-gamble-singapore-pte-ltd
